We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BIOX market cap is 873.51M. The company's latest EPS is USD 0.3213 and P/E is 33.89.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 93.19M | -126.4M | 326.2M | 116.59M | 140.2M |
| Operating Income | 2.22M | 12.03M | 27.51M | 5.3M | 16.7M |
| Net Income | -8.43M | 31.99M | -7.68M | -2.68M | 1.2M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 160.97M | 173.09M | 209.53M | 334.8M | 416.79M |
| Operating Income | 32.09M | 39.15M | 38.38M | 39.87M | 54.18M |
| Net Income | -16.36M | 4.24M | -3.82M | -3.91M | 20.18M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 872.85M | 845.87M | 824.1M | 819.7M | 817.2M |
| Total Liabilities | 566.24M | 511.6M | 494M | 487.07M | 481.9M |
| Total Equity | 306.62M | 334.27M | 330.1M | 332.62M | 335.3M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 242.47M | 297.56M | 394.59M | 518.22M | 818.06M |
| Total Liabilities | 180.37M | 236.81M | 304.3M | 359.92M | 487.56M |
| Total Equity | 62.1M | 60.75M | 90.29M | 158.3M | 330.5M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 8.83M | N/A | N/A | 14.73M | N/A |
| Investing | -19.22M | N/A | N/A | -8.69M | N/A |
| Financing | 40.35M | N/A | N/A | -26.98M | N/A |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 29.7M | 11.42M | -6.21M | -17.52M | 2.59M |
| Investing | -3.26M | -22.21M | -8.31M | 2.9M | -25.73M |
| Financing | -26.95M | 33.53M | 7.36M | 14.82M | 32.95M |
| Market Cap | 873.51M |
| Price to Earnings Ratio | 33.89 |
| Price to Sales Ratio | 1.64 |
| Price to Cash Ratio | 14.21 |
| Price to Book Ratio | 2.07 |
| Dividend Yield | - |
| Shares Outstanding | 62.8M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.22 (8.23%) |
| Company Name | Bioceres Crop Solutions Corp |
| Address |
ocampo 210 bis rosario, santa fe |
| Website | https://biocerescrops.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
